SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹24 Cr | ₹21 Cr | ₹23 Cr | ₹8.35 Cr | - |
What is the latest Contingent Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹24 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹8.35 Cr |
| Mar2022 | - |
How is Contingent Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹24 Cr | 16.72 | |
| Mar2025 | ₹21 Cr | -8.88 | |
| Mar2024 | ₹23 Cr | 174.99 | |
| Mar2023 | ₹8.35 Cr | 0 | |
| Mar2022 | - | - | |
Compare Contingent Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,103.9 Cr | 10.1% | -2.4% | 74.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 10.1% |
-2.4% |
74.6% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses